At the conference, Antengene shared the latest data and clinical development plans for its core clinical asset, ATG-022 (a CLDN18.2 antibody-drug conjugate [ADC]), as well as R&D progress on ATG-125 ...
Baba-Ahmed urged Atiku Abubakar to step aside and drop plans to contest the 2027 presidential election He said Atiku’s withdrawal would signal a break from recycled politics and inspire a new ...